Pharmaceutically active compounds
    19.
    发明授权
    Pharmaceutically active compounds 失效
    药物活性化合物

    公开(公告)号:US06492406B1

    公开(公告)日:2002-12-10

    申请号:US09646972

    申请日:2000-09-25

    IPC分类号: C07D40314

    摘要: The present invention relates to novel compounds which are protein kinase C inhibitors, methods for their preparation, intermediates therefor and pharmaceutical compositions comprising them. More particularly, the present invention relates to compounds of formula (I): wherein: one of Ar1 and Ar2 is optionally substituted bicyclic heteroaryl or optionally substituted tricyclic heteroaryl and the other is optionally substituted heteroaryl or optionally substituted aryl; X is O or S; and R is H, OH, NH2 or C1-6 alkyl (itself optionally substituted by amino or hydroxy); or a salt or solvate thereof, or a solvate of a salt thereof; and the use of such compounds in medical therapies.

    摘要翻译: 本发明涉及蛋白激酶C抑制剂的新化合物,其制备方法,其中间体和包含它们的药物组合物。 更具体地说,本发明涉及式(I)的化合物:其中:Ar 1和Ar 2之一是任选取代的双环杂芳基或任选取代的三环杂芳基,另一个是任选取代的杂芳基或任选取代的芳基; X是O或S; 且R为H,OH,NH 2或C 1-6烷基(其本身任选被氨基或羟基取代); 或其盐或溶剂合物,或其盐的溶剂合物; 以及这些化合物在医学疗法中的应用。